Yahoo Web Search

  1. Business Standard describes pharma vehicles as laggards over the past year, with an average return of only 1.74% and returns of 4.9% compounded annually over the past five years. It would seem ...

  2. Vertex is also developing drugs for treating pain in addition to other rare genetic diseases, including alpha-1 antitrypsin deficiency (AATD), beta-thalassemia, Duchenne muscular dystrophy ...

  1. Ads
    related to AATD